Early propranolol treatment ameliorates endothelial dysfunction in experimental septic lung.

ÖZYILMAZ, EZGİ; Buyuknacar, HACER; Bagir, EMİNE; SENCAR, LEMAN; Ozturk, ÖZLEM; ERAY, İSMAİL; DAĞLIOĞLU, YUSUF; Baydar, OYA; SEYDAOĞLU, GÜLŞAH; METE, UFUK; Gumurdulu, Derya; Kocabas, Ali

doi:10.17219/acem/78248

Early propranolol treatment ameliorates endothelial dysfunction in experimental septic lung.

ÖZYILMAZ E., Buyuknacar H. S., Bagir E. K., SENCAR L., Ozturk Ö., ERAY İ. C., ...Daha Fazla

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, cilt.28, sa.3, ss.291-297, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 28 Sayı: 3
Basım Tarihi: 2019
Doi Numarası: 10.17219/acem/78248
Dergi Adı: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.291-297
Anahtar Kelimeler: sepsis, endothelial dysfunction, experimental, beta-blockers, HEART-RATE CONTROL, BETA-BLOCKERS, THERMAL-INJURY, SEVERE SEPSIS, SHOCK, SURVIVAL, ACTIVATION, NEBIVOLOL, ESMOLOL
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Çukurova Üniversitesi Adresli: Evet

Özet

Background. Recent reports have indicated an improved prognosis in sepsis with beta blocker agents; however, the underlying action mechanism is still under debate.